Negative Predictive Value of Human Papillomavirus Testing: Implications for Anal Cancer Screening in People Living with HIV/AIDS.
Journal
Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537
Informations de publication
Date de publication:
2020
2020
Historique:
received:
07
09
2019
revised:
07
12
2019
accepted:
30
12
2019
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
16
5
2020
Statut:
epublish
Résumé
People living with HIV/AIDS (PLWHA) have an increased incidence of anal squamous cell carcinoma. Since high-risk human papillomavirus (hrHPV) is the primary cause, hrHPV DNA testing may play an important role in anal cancer screening. This study aims to determine the negative predictive value (NPV) of hrHPV testing in PLWHA as well as factors that may lead to false-negative results. Anal swabs were collected for cytology and Cobas® 4800 HPV test for 14 hrHPV types. Patients underwent concomitant high-resolution anoscopy (HRA) examination and biopsy. High-grade squamous intraepithelial lesions (HSIL, synonymous with anal intraepithelial neoplasia AIN2 and 3) detected in Cobas-negative patients were genotyped for 22 HPV types using BioPerfectus Multiplex Real-time PCR. 156 PLWHA tested negative for hrHPV on anal swab samples (i.e., Cobas-negative). HRA-guided biopsy detected HSIL/AIN3 in 13 patients (8%, NPV 92%), HSIL/AIN2 in 5 patients (3%), low-grade squamous intraepithelial lesions in 82 (LSIL, 53%), or benign findings in 56 (36%). No cancer was found. The HSIL group was similar to the LSIL/benign group regarding age, gender, race/ethnicity, clinical HIV parameters, cytological diagnoses, history of receptive anal sex, and smoking ( In this series, anal hrHPV DNA testing offered 92% NPV for PLWHA; in other words, a 8% risk of occult precancer remains for those who test hrHPV negative on anal swab samples.
Identifiants
pubmed: 32411239
doi: 10.1155/2020/6352315
pmc: PMC7204264
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6352315Informations de copyright
Copyright © 2020 Yiying Wang et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Int J Cancer. 2017 May 15;140(10):2192-2200
pubmed: 28006858
AIDS. 2005 Sep 2;19(13):1407-14
pubmed: 16103772
Am J Surg Pathol. 2013 Sep;37(9):1299-310
pubmed: 24076770
J Clin Virol. 2006 Aug;36(4):277-82
pubmed: 16765639
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):45-6
pubmed: 23932300
Lancet Infect Dis. 2018 Feb;18(2):198-206
pubmed: 29158102
AIDS. 2010 Sep 24;24(15):2355-63
pubmed: 20706109
JAMA. 2018 Aug 21;320(7):674-686
pubmed: 30140884
J Natl Cancer Inst. 2015 Apr 29;107(6):djv086
pubmed: 25925419
PLoS One. 2015 Apr 07;10(4):e0123590
pubmed: 25849412
Int J Cancer. 2012 Oct 1;131(7):1641-8
pubmed: 22234750
J Infect Dis. 2018 Oct 20;218(11):1746-1752
pubmed: 30053247
IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636
pubmed: 18354839
BMC Cancer. 2015 Nov 06;15:860
pubmed: 26546160
Cancer Cytopathol. 2018 Jul;126(7):447-460
pubmed: 29797691
AIDS. 2012 Nov 13;26(17):2185-92
pubmed: 23018436
AIDS. 2017 Oct 23;31(16):2227-2233
pubmed: 28723712
AIDS. 2010 Jun 1;24(9):1307-13
pubmed: 20442633
Dimens Crit Care Nurs. 2017 Jan/Feb;36(1):22-29
pubmed: 27902658
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Clin Infect Dis. 2014 Jan;58(1):e1-34
pubmed: 24235263
J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):491-9
pubmed: 18614927
Clin Infect Dis. 2019 Nov 27;69(12):2185-2192
pubmed: 30770528
Dis Colon Rectum. 1997 Aug;40(8):919-28
pubmed: 9269808
Arch Pathol Lab Med. 2013 Nov;137(11):1550-4
pubmed: 24168493
Am J Clin Pathol. 2011 Mar;135(3):468-75
pubmed: 21350104
J Infect Dis. 2018 Mar 5;217(6):953-963
pubmed: 29211874
Int J Gynecol Pathol. 2013 Jan;32(1):76-115
pubmed: 23202792
Clin Infect Dis. 2012 Apr;54(7):1026-34
pubmed: 22291097
AIDS. 2010 Feb 20;24(4):535-43
pubmed: 19926961
Clin Microbiol Rev. 2016 Apr;29(2):291-319
pubmed: 26912568
Infect Agent Cancer. 2009 Jun 01;4:8
pubmed: 19486508
Diagn Cytopathol. 2010 Jul;38(7):538-46
pubmed: 19941374
PLoS One. 2013 Nov 12;8(11):e78291
pubmed: 24265682
Int J Cancer. 2013 Nov;133(9):2253-8
pubmed: 23616200